Suzanne M. Jan de Beur, MD
Following an extensive nationwide search, Suzanne M. Jan de Beur, MD, has been appointed Associate Dean for Clinical Research, effective May 18, 2026. Dr. Jan de Beur succeeds Linda Duska, MD, who has dedicated many years of service and significant contributions to advancing clinical research within the School of Medicine.
Working collaboratively with Senior Associate Dean for Research Jeffrey Martens, PhD, Dr. Jan de Beur will oversee, lead, and further develop the School of Medicine’s institutional clinical research enterprise. In this role, she will develop strategies and resources to expand clinical research across the School of Medicine, advocate for clinical investigators, strengthen clinical research infrastructure, and foster research synergies across Grounds and with our community partners.
Dr. Jan de Beur has a distinguished record as a physician-scientist, practicing endocrinologist, mentor, and academic leader. She graduated from Cornell University and Weill Cornell Medical College, completed the Osler Medical Residency at The Johns Hopkins Hospital, and completed fellowship training in endocrinology and metabolism at the Johns Hopkins University School of Medicine. Before joining UVA in 2023 as Chief of the Division of Endocrinology and Metabolism, she served on the faculty at Johns Hopkins for 25 years, where she held numerous leadership roles spanning clinical care, clinical research operations, and translational research infrastructure. These included Director of Endocrinology and Metabolism at Johns Hopkins Bayview, Director of the Johns Hopkins Clinical Research Unit Network, and Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. In these roles, she helped manage CTSA-supported clinical and translational research infrastructure and led a network of six clinical research units across adult and pediatric, inpatient and outpatient, academic, community hospital, and community-based settings.
Dr. Jan de Beur’s clinical and research work focuses on rare and metabolic bone diseases, with an emphasis on translating basic scientific discoveries into improved patient care. Her work has advanced the identification and molecular characterization of several disorders of mineral metabolism, including pseudohypoparathyroidism, progressive osseous heteroplasia, and tumor-induced osteomalacia, and has helped reshape diagnostic and therapeutic approaches for X-linked hypophosphatemia, tumor-induced osteomalacia, and osteogenesis imperfecta. She also brings extensive experience leading complex clinical trials and multi-site clinical research programs, including serving as Coordinating Principal Investigator.
Dr. Jan de Beur is a member of several professional and honorific societies, including the Association of Osteobiology. She is a Past President and Fellow of the American Society for Bone and Mineral Research (ASBMR) and has received the Shirley Hohl and Boy Frame Award from ASBMR.
The School of Medicine is pleased to congratulate and welcome Dr. Jan de Beur to this important leadership role.